Human and murine breast cancer growth and metastasis require regulatory immune cells, such as regulatory T cells (FoxP3+Tregs), B cells (Bregs), and myeloid-derived suppressor cells (MDSCs) to inhibit antitumor immune cells28–32. Here, FOXP3 is linked to breast carcinoma.